Literature DB >> 21576297

Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades.

Finlay A McAlister1, Kathryn Wilkins, Michel Joffres, Frans H H Leenen, George Fodor, Marianne Gee, Mark S Tremblay, Robin Walker, Helen Johansen, Norm Campbell.   

Abstract

BACKGROUND: Analyses of medication databases indicate marked increases in prescribing of antihypertensive drugs in Canada over the past decade. This study was done to examine the trends in the prevalence of hypertension and in control rates in Canada between 1992 and 2009.
METHODS: Three population-based surveys, the 1986-1992 Canadian Heart Health Surveys, the 2006 Ontario Survey on the Prevalence and Control of Hypertension and the 2007-2009 Canadian Health Measures Survey, collected self-reported health information from, and measured blood pressure among, community-dwelling adults.
RESULTS: The population prevalence of hypertension was stable between 1992 and 2009 at 19.7%-21.6%. Hypertension control improved from 13.2% (95% confidence interval [CI] 10.7%-15.7%) in 1992 to 64.6% (95% CI 60.0%-69.2%) in 2009, reflecting improvements in awareness (from 56.9% [95% CI 53.1%-60.5%] in 1992 to 82.5% [95% CI 78.5%-86.0%] in 2009) and treatment (from 34.6% [95% CI 29.2%-40.0%] in 1992 to 79.0% [95% CI 71.3%-86.7%] in 2009) among people with hypertension. The size of improvements in awareness, treatment and control were similar among people who had or did not have cardiovascular comorbidities Although systolic blood pressures among patients with untreated hypertension were similar between 1992 and 2009 (ranging from 146 [95% CI 145-147] mm Hg to 148 [95% CI 144-151] mm Hg), people who did not have hypertension and patients with hypertension that was being treated showed substantially lower systolic pressures in 2009 than in 1992 (113 [95% CI 112-114] v. 117 [95% CI 117-117] mm Hg and 128 [95% CI 126-130] v. 145 [95% CI 143-147] mm Hg).
INTERPRETATION: The prevalence of hypertension has remained stable among community-dwelling adults in Canada over the past two decades, but the rates for treatment and control of hypertension have improved markedly during this time.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576297      PMCID: PMC3114892          DOI: 10.1503/cmaj.101767

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  33 in total

1.  Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine.

Authors:  D J Hyman; V N Pavlik
Journal:  Arch Intern Med       Date:  2000 Aug 14-28

2.  From knowledge to practice in chronic cardiovascular disease: a long and winding road.

Authors:  Sumit R Majumdar; Finlay A McAlister; Curt D Furberg
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

3.  Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease.

Authors:  Jonathan Emberson; Peter Whincup; Richard Morris; Mary Walker; Shah Ebrahim
Journal:  Eur Heart J       Date:  2004-03       Impact factor: 29.983

4.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

Review 5.  Variance estimation for complex surveys using replication techniques.

Authors:  K F Rust; J N Rao
Journal:  Stat Methods Med Res       Date:  1996-09       Impact factor: 3.021

6.  Physician-related barriers to the effective management of uncontrolled hypertension.

Authors:  Susan A Oliveria; Pablo Lapuerta; Bruce D McCarthy; Gilbert J L'Italien; Dan R Berlowitz; Steven M Asch
Journal:  Arch Intern Med       Date:  2002-02-25

7.  A survey of clinician attitudes and management practices in hypertension.

Authors:  F A McAlister; A Laupacis; K K Teo; P G Hamilton; T J Montague
Journal:  J Hum Hypertens       Date:  1997-07       Impact factor: 3.012

Review 8.  Worldwide prevalence of hypertension: a systematic review.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul K Whelton; Jiang He
Journal:  J Hypertens       Date:  2004-01       Impact factor: 4.844

9.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

10.  Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex.

Authors:  Nathan D Wong; Gaurav Thakral; Stanley S Franklin; Gil J L'Italien; Milagros J Jacobs; Joanna L Whyte; Pablo Lapuerta
Journal:  Am Heart J       Date:  2003-05       Impact factor: 4.749

View more
  100 in total

Review 1.  The 2015 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.

Authors:  Sherilyn K D Houle; Raj Padwal; Luc Poirier; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2015-07

2.  Recommendations on screening for high blood pressure in Canadian adults.

Authors:  Patrice Lindsay; Sarah Connor Gorber; Michel Joffres; Richard Birtwhistle; Donald McKay; Lyne Cloutier
Journal:  Can Fam Physician       Date:  2013-09       Impact factor: 3.275

3.  Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update.

Authors:  Sarah A Lamb; Yazid N Al Hamarneh; Sherilyn K D Houle; Alexander A Leung; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2017-11-29

4.  Factors associated with hypertension prevalence, awareness, treatment and control among participants in the International Mobility in Aging Study (IMIAS).

Authors:  B Doulougou; F Gomez; B Alvarado; R O Guerra; A Ylli; J Guralnik; M V Zunzunegui
Journal:  J Hum Hypertens       Date:  2015-04-02       Impact factor: 3.012

5.  The 2012-2013 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.

Authors:  Sherilyn K D Houle; Raj Padwal; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2013-05

6.  Independent and interactive impacts of hypertension and diabetes mellitus on verbal memory: A coordinated analysis of longitudinal data from England, Sweden, and the United States.

Authors:  Amanda Kelly; Matthew Calamia; Andrey Koval; Graciela Muniz Terrera; Andrea M Piccinin; Sean Clouston; Linda B Hassing; David A Bennett; Boo Johansson; Scott M Hofer
Journal:  Psychol Aging       Date:  2016-02-25

7.  Hypertension prevalence, awareness, treatment, and control in northeast China: a population-based cross-sectional survey.

Authors:  Fu-Liang Zhang; Zhen-Ni Guo; Ying-Qi Xing; Yan-Hua Wu; Hao-Yuan Liu; Yi Yang
Journal:  J Hum Hypertens       Date:  2017-11-27       Impact factor: 3.012

8.  The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States.

Authors:  Finlay A McAlister; Cynthia Robitaille; Cathleen Gillespie; Keming Yuan; Deepa P Rao; Steven Grover; Sulan Dai; Helen Johansen; Michel Joffres; Fleetwood Loustalot; Norm Campbell
Journal:  Can J Cardiol       Date:  2013-03-01       Impact factor: 5.223

9.  Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis.

Authors:  Luísa Lima Castro; Cristina Costa Duarte Lanna; Mariana Pimenta Rocha; Antônio Luiz Pinho Ribeiro; Rosa Weiss Telles
Journal:  Rheumatol Int       Date:  2018-06-15       Impact factor: 2.631

10.  Effectiveness of Self-Monitoring Blood Pressure in Primary Care: A Randomized Controlled Trial.

Authors:  Wichai Aekplakorn; Paibul Suriyawongpaisal; Rassamee Tansirisithikul; Thida Sakulpipat; Phikul Charoensuk
Journal:  J Prim Care Community Health       Date:  2015-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.